CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010

28 MMWR June 18, 2010
359. Rahm VA, Odlind V, Pettersson R. Chlamydia trachomatis in sexually
active teenage girls. Factors related to genital chlamydial infection: a
prospective study. Genitourin Med 1991;67:317–21.
360. Reed BD, Huck W, Zazove P. Differentiation of Gardnerella vaginalis,
Candida albicans, and Trichomonas vaginalis infections of the vagina.
J Fam Pract 1989;28:673–80.
361. Ripa KT, Svensson L, Mardh PA, Westrom L. Chlamydia trachomatis
cervicitis in gynecologic outpatients. Obstet Gynecol
1978;52:698–702.
362. Ruijs GJ, Kauer FM, van Gijssel PM, Schirm J, Schroder FP. Direct
immunofluorescence for Chlamydia trachomatis on urogenital smears
for epidemiological purposes. Eur J Obstet Gynecol Reprod Biol
1988;27:289–97.
363. Schachter J, Stoner E, Moncada J. Screening for chlamydial infections
in women attending family planning clinics. West J Med
1983;138:375–9.
364. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance
and predictors of human papillomavirus infection in women. Can Med
Assoc J 2003;168:421–5.
365. Sessa R, Latino MA, Magliano EM, et al. Epidemiology of urogenital
infections caused by Chlamydia trachomatis and outline of characteristic
features of patients at risk. J Med Microbiol 1994;41:168–72.
366. Shafer MA, Beck A, Blain B, et al. Chlamydia trachomatis: important
relationships to race, contraception, lower genital tract infection, and
Papanicolaou smear. J Pediatr 1984;104:141–6.
367. Smith JS, Herrero R, Munoz N, et al. Prevalence and risk factors for
herpes simplex virus type 2 infection among middle-age women in
Brazil and the Philippines. Sex Transm Dis 2001;28:187–94.
368. Staerfelt F, Gundersen TJ, Halsos AM, et al. A survey of genital infections
in patients attending a clinic for sexually transmitted diseases.
Scand J Infect Dis Suppl 1983;40:53–7.
369. Svensson L, Westrom L, Mardh PA. Chlamydia trachomatis in women
attending a gynaecological outpatient clinic with lower genital tract
infection. Br J Vener Dis 1981;57:259–62.
370. Tait IA, Rees E, Hobson D, Byng RE, Tweedie MC. Chlamydial infection
of the cervix in contacts of men with nongonococcal urethritis. Br
J Vener Dis 1980;56:37–45.
371. Vaccarella S, Herrero R, Dai M, et al. Reproductive factors, oral contraceptive
use, and human papillomavirus infection: pooled analysis
of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers
Prev 2006;15:2148–53.
372. Willmott FE, Mair HJ. Genital herpesvirus infection in women attending
a venereal diseases clinic. Br J Vener Dis 1978;54:341–3.
373. Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus
infection: incidence and risk factors in a cohort of female university students.
Am J Epidemiol 2003;157:218–26. Erratum in Am J Epidemiol.
2003;157:858.
374. Winter L, Goldy AS, Baer C. Prevalence and epidemiologic correlates
of Chlamydia trachomatis in rural and urban populations. Sex Transm
Dis 1990;17:30–6.
375. Wolinska WH, Melamed MR. Herpes genitalis in women attending
Planned Parenthood of New York City. Acta Cytol 1970;14:239–42.
376. Woolfitt JM, Watt L. Chlamydial infection of the urogenital tract
in promiscuous and non-promiscuous women. Br J Vener Dis
1977;53:93–5.
377. European Study Group on Heterosexual Transmission of HIV.
Comparison of female to male and male to female transmission of
HIV in 563 stable couples. BMJ 1992;304:809–13.
378. Aklilu M, Messele T, Tsegaye A, et al. Factors associated with HIV-1
infection among sex workers of Addis Ababa, Ethiopia. AIDS
2001;15:87–96.
379. Allen S, Serufilira A, Gruber V, et al. Pregnancy and contraception use
among urban Rwandan women after HIV testing and counseling. Am
J Public Health 1993;83:705–10.
380. Baeten JM, Benki S, Chohan V, et al. Hormonal contraceptive use,
herpes simplex virus infection, and risk of HIV-1 acquisition among
Kenyan women. AIDS 2007;21:1771–7.
381. Chao A, Bulterys M, Musanganire F, et al. Risk factors associated
with prevalent HIV-1 infection among pregnant women in Rwanda.
National University of Rwanda–Johns Hopkins University AIDS
Research Team. Int J Epidemiol 1994;23:371–80.
382. Cohen CR, Duerr A, Pruithithada N, et al. Bacterial vaginosis and
HIV seroprevalence among female commercial sex workers in Chiang
Mai, Thailand. AIDS 1995;9:1093–7.
383. Criniti A, Mwachari CW, Meier AS, et al. Association of hormonal
contraception and HIV-seroprevalence in Nairobi, Kenya. AIDS
2003;17:2667–9.
384. de Vincenzi I. A longitudinal study of human immunodeficiency
virus transmission by heterosexual partners. European Study Group
on Heterosexual Transmission of HIV [comment]. N Engl J Med
1994;331:341–6.
385. Ellerbrock TV, Lieb S, Harrington PE, et al. Heterosexually transmitted
human immunodeficiency virus infection among pregnant
women in a rural Florida community [comment]. N Engl J Med
1992;327:1704–9.
386. Gray JA, Dore GJ, Li Y, et al. HIV-1 infection among female commercial
sex workers in rural Thailand. AIDS 1997;11:89–94.
387. Guimaraes MD, Munoz A, Boschi-Pinto C, Castilho EA. HIV infection
among female partners of seropositive men in Brazil. Rio de Janeiro
Heterosexual Study Group. Am J Epidemiol 1995;142:538–47.
388. Hira SK, Kamanga J, Macuacua R, Feldblum PJ. Oral contraceptive
use and HIV infection. Int J STD AIDS 1990;1:447–8.
389. Kapiga SH, Shao JF, Lwihula GK, Hunter DJ. Risk factors for HIV
infection among women in Dar-es-Salaam, Tanzania. J Acquir Immune
Defic Syndr 1994;7:301–9.
390. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of
HIV infection among women using family planning methods in Dar
es Salaam, Tanzania. AIDS 1998;12:75–84.
391. Kilmarx PH, Limpakarnjanarat K, Mastro TD, et al. HIV-1 seroconversion
in a prospective study of female sex workers in northern
Thailand: continued high incidence among brothel-based women.
AIDS 1998;12:1889–98.
392. Kunanusont C, Foy HM, Kreiss JK, et al. HIV-1 subtypes and maleto-female
transmission in Thailand. Lancet 1995;345:1078–83.
393. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted
diseases as risk factors for HIV-1 transmission in women: results
from a cohort study [comment]. AIDS 1993;7:95–102.
394. Lavreys L, Baeten JM, Martin HL, Jr., et al. Hormonal contraception
and risk of HIV-1 acquisition: results of a 10-year prospective study.
AIDS 2004;18:695–7.
395. Limpakarnjanarat K, Mastro TD, Saisorn S, et al. HIV-1 and other
sexually transmitted infections in a cohort of female sex workers in
Chiang Rai, Thailand. Sex Transm Infect 1999;75:30–5.
396. Martin HL, Jr, Nyange PM, Richardson BA, et al. Hormonal contraception,
sexually transmitted diseases, and risk of heterosexual
transmission of human immunodeficiency virus type 1. J Infect Dis
1998;178:1053–9.